Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis [2]

Pharmacometrics

Gastroenterology

CPT Pharmacometrics Syst Pharmacol. 2022 Sep;11(9):1244-1255

Moein A, Lu T, Jönsson S, Ribbing J, Kassir N, Zhang W, Sperinde G, Zhang R, Tang M, Oh YS, Bruno R

External authors

Kassir N,

Moein A,

Zhang R,

Tang M,

Oh YS,

Zhang W,

Lu T,

Sperinde G

Pharmetheus collaborators

Jakob Ribbing